Actively Recruiting

Age: 40Years +
All Genders
NCT07118306

COPD Exacerbation Follow Up

Led by Viz.ai, Inc. · Updated on 2026-04-30

485

Participants Needed

2

Research Sites

91 weeks

Total Duration

On this page

Sponsors

V

Viz.ai, Inc.

Lead Sponsor

S

Sanofi

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.

CONDITIONS

Official Title

COPD Exacerbation Follow Up

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 40 years or older at the time of arrival to the emergency department.
  • Patients with a clinical diagnosis of COPD who present to the emergency department for a moderate or severe COPD exacerbation.
  • A moderate exacerbation is defined as an acute exacerbation requiring either systemic corticosteroids (such as intramuscular, intravenous or oral) and/or antibiotics.
  • A severe exacerbation is defined as an acute exacerbation requiring hospitalization, or observation for >24 hours in emergency department/urgent care facility or resulting in death.
  • Patients on dual (LABA/LAMA, LABA/ICS, LAMA/ICS) or triple (LABA/LAMA/ICS) long-acting bronchodilator inhalers.
Not Eligible

You will not qualify if you...

  • Patients on bronchodilator inhaler monotherapy.
  • Patients leaving against medical advice or expiring during hospitalization.
  • Patients with tracheostomy.
  • Patients with advanced cancer.
  • Patients who have received a lung transplant.
  • Discharge to hospice care.
  • Transfer to another hospital.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Cooper University Health Care

Cherry Hill, New Jersey, United States, 08002

Actively Recruiting

2

Thomas Jefferson University

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

COPD Exacerbation Follow Up | DecenTrialz